{
    "clinical_study": {
        "@rank": "20153", 
        "acronym": "SLIMMER", 
        "arm_group": [
            {
                "arm_group_label": "Combined lifestyle intervention", 
                "arm_group_type": "Experimental", 
                "description": "Lifestyle counselling (nutrition and physical activity) by dietician and physiotherapist during 10-month intervention period"
            }, 
            {
                "arm_group_label": "Usual care group", 
                "arm_group_type": "Other", 
                "description": "Subjects receive brochures on healthy lifestyle at baseline, and during the 10-month intervention period only usual care as provided by their own general practitioner."
            }
        ], 
        "brief_summary": {
            "textblock": "The overall aim of the project is to evaluate the (cost-)effectiveness of the SLIMMER\n      diabetes prevention intervention in Dutch primary health care."
        }, 
        "brief_title": "(Cost-)Effectiveness of SLIMMER Diabetes Prevention Intervention", 
        "completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Diabetes Mellitus Type 2", 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 2"
            ]
        }, 
        "detailed_description": {
            "textblock": "This is a randomised controlled trial, conducted in a real-life setting (Dutch primary\n      health care)."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age 40-70 years\n\n          -  Impaired fasting glucose (IFG; i.e. venous plasma glucose concentration \u22656.1 and\n\n             \u22646.9 mmol/l) during the past 5 years, according to the GP registration database OR\n             diabetes risk score \u22657 as calculated from the Diabetes Risk Test\n\n          -  Willing and able to participate in the intervention for at least 1.5 years\n\n          -  Dutch speaking\n\n        Exclusion Criteria:\n\n          -  Known diabetes mellitus\n\n          -  Any chronic illness that makes 1.5-years survival improbable, interferes with glucose\n             tolerance, or makes participation in a lifestyle intervention impossible\n\n          -  Patients with any severe cardiovascular disease (this also includes history of\n             cardiac dysrhythmia), unless GP gives agreement\n\n          -  Medication known to interfere with glucose tolerance\n\n          -  Any mental or physical disability that will hinder participation in the lifestyle\n             intervention\n\n          -  Severe psychiatric disease\n\n          -  Patients who showed bad compliance in the past\n\n          -  Participation in another regular vigorous exercise and/or diet programme, i.e.:\n\n               -  Intensive exercise programme: any exercise programme offered by a\n                  physiotherapist and/or patients sporting at least 3 times a week at their own\n                  initiative.\n\n               -  Intensive diet programme: patients who visited a dietician at least 3 times\n                  during the last year."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "40 Years"
        }, 
        "enrollment": {
            "#text": "316", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 19, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02094911", 
            "org_study_id": "NL37994.081.11"
        }, 
        "intervention": [
            {
                "arm_group_label": "Combined lifestyle intervention", 
                "description": "10-month intervention period with:\nweekly group-based sports lessons supervised by a physiotherapist\nindividual dietary advice by a dietician\ncase management by practice nurse\nmaintenance programme to guide subjects to maintain lifestyle behaviour change", 
                "intervention_name": "Combined lifestyle intervention", 
                "intervention_type": "Behavioral", 
                "other_name": "SLIMMER intervention"
            }, 
            {
                "arm_group_label": "Usual care group", 
                "description": "Written information on healthy lifestyle was provided at baseline, no individual advice or programme was provided. No additional appointments were scheduled, apart from the visits for follow-up measurements", 
                "intervention_name": "Usual care group", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Prevention", 
            "Combined lifestyle intervention", 
            "Primary health care"
        ], 
        "lastchanged_date": "March 19, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Wageningen", 
                    "country": "Netherlands"
                }, 
                "name": "Wageningen University"
            }
        }, 
        "location_countries": {
            "country": "Netherlands"
        }, 
        "number_of_arms": "2", 
        "official_title": "Implementation and (Cost-)Effectiveness of Diabetes Prevention in Dutch Primary Health Care: From SLIM to SLIMMER", 
        "overall_official": {
            "affiliation": "Wageningen University", 
            "last_name": "Edith Feskens, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": [
                "Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)", 
                "Netherlands: Medical Ethics Review Committee (METC)"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Change in fasting insulin", 
            "safety_issue": "No", 
            "time_frame": "Baseline, end of intervention (12 months), after follow-up (18 months)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02094911"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "fasting glucose, 2h glucose, 2h insulin, HbA1c", 
                "measure": "Glucose tolerance", 
                "safety_issue": "No", 
                "time_frame": "Baseline, end of intervention (12 months), after follow-up (18 months)"
            }, 
            {
                "description": "total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides", 
                "measure": "Serum lipids", 
                "safety_issue": "No", 
                "time_frame": "Baseline, end of intervention (12 months), after follow-up (18 months)"
            }, 
            {
                "description": "body weight, BMI, waist and hip circumference, body fat", 
                "measure": "Body fatness", 
                "safety_issue": "No", 
                "time_frame": "Baseline, end of intervention (12 months), after follow-up (18 months)"
            }, 
            {
                "description": "measured with six-minute walk test", 
                "measure": "Physical fitness", 
                "safety_issue": "No", 
                "time_frame": "Baseline, end of intervention (12 months), after follow-up (18 months)"
            }, 
            {
                "measure": "Blood pressure", 
                "safety_issue": "No", 
                "time_frame": "Baseline, end of intervention (12 months), after follow-up (18 months)"
            }, 
            {
                "measure": "Medication use", 
                "safety_issue": "No", 
                "time_frame": "Baseline, end of intervention (12 months), after follow-up (18 months)"
            }, 
            {
                "measure": "Quality of Life", 
                "safety_issue": "No", 
                "time_frame": "Baseline, end of intervention (12 months), after follow-up (18 months)"
            }, 
            {
                "description": "Measured as nutrient intake and food intake, with a Food Frequency Questionnaire", 
                "measure": "Eating behaviour", 
                "safety_issue": "No", 
                "time_frame": "Baseline, end of intervention (12 months), after follow-up (18 months)"
            }, 
            {
                "description": "Measured with questionnaire", 
                "measure": "Physical activity behaviour", 
                "safety_issue": "No", 
                "time_frame": "Baseline, end of intervention (12 months), after follow-up (18 months)"
            }, 
            {
                "description": "Determinants of nutrition and physical activity behaviour, measured with questionnaire", 
                "measure": "Behavioural determinants", 
                "safety_issue": "No", 
                "time_frame": "Baseline, end of intervention (12 months), after follow-up (18 months)"
            }, 
            {
                "description": "Indicators to investigate how the intervention was delivered and received, measured with quantitative and qualitative methods", 
                "measure": "Process indicators", 
                "safety_issue": "No", 
                "time_frame": "Baseline, end of intervention (12 months), after follow-up (18 months)"
            }
        ], 
        "source": "Wageningen University", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "ZonMw: The Netherlands Organisation for Health Research and Development", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Dutch Diabetes Research Foundation", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Wageningen University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}